Skin Cancer Detection App

Please note: Limited to 1 access link per transaction.
Skinvision is not available to individuals located in the USA.

Check a suspicious spot anywhere, anytime by simply taking a photo on your smartphone for a 12-month period.

After significant research into skin cancer detection technology, Solbari has teamed up with SkinVision to enable you to check for skin cancer cost-effectively and in the privacy of your own home.

The 12-month access period includes unlimited skin checks and support via SkinVision’s peer-reviewed team of skin specialists.

SkinVision is a proven technology used by over 1 million users and has enabled over 40,000 skin cancers to be detected globally to date. SkinVision has won a number of healthcare technology awards and is trusted by large health insurance companies and Government healthcare systems including the NHS in the UK.

How it works:

• Purchase the SkinVision App here at a discounted price
• We will send you a unique link by email which will enable you to download the SkinVision App onto your smartphone
• Use the App to take photos of your moles and skin spots
• Get an instant risk recommendation (low/medium /high risk) and advice on what to do next
• Track and catalogue your moles and skin spots to check for changes in shape or size

Immediate clinical insights

The advanced technology analyses your photo using our clinically validated algorithm to provide an instant risk recommendation and advice on what to do next.

Track your skin spots ongoing

Set skin check reminders and catalogue your moles and skin spots to track any changes over time. All photos taken by SkinVision are subject to strict data privacy regulations.

Clinically validated, dermatologist supported & award-winning

The SkinVision app is a regulated and CE marked medical service. The clinically validated algorithm has been able to detect high-risk skin lesions with 95% accuracy rate. It’s supported by world-class dermatologists and celebrated around the world for its life-changing effectiveness.

We want to emphasise that the SkinVision does not reduce the importance of getting a suspicious lesion checked by a medical expert. There is functionality in the SkinVision app which allows to share stored photos taken by SkinVision with your healthcare professional. If you are not comfortable with the SkinVision risk assessment, we recommend that you immediately get a second opinion. Whether an assessment is done by a human or a machine-learning algorithm like SkinVision there are ultimately limitations which can only be resolved by pathology. Neither are an absolute guarantee in terms of accuracy and we are certainly not representing that SkinVision provides that.